84-5442-71 [取扱停止]Cot, phosphorylated (Ser400) 100ul 535005
特徴
- MAP3K8 is an oncogene that encodes a member of the serine/threonine protein kinase family.
- The mitogen-activated protein kinase kinase kinase 8 localizes to the cytoplasm and can activate both the MAP kinase and JNK kinase pathways.
- This protein was shown to activate IkappaB kinases, and thus induce the nuclear production of NF-kappaB.
- This protein was also found to promote the production of TNF-alpha and IL-2 during T lymphocyte activation.
- MAP3K8 may also utilize a downstream in-frame translation start codon, and thus produce an isoform containing a shorter N-terminal.
- The shorter isoform has been shown to display weaker transforming activity.
- Alternate splicing results in multiple transcript variants that encode the same protein.
- Applications:Suitable for use in Immunohistochemistry and ELISA.
- Other applications not tested.
- Recommended Dilution:Immunohistochemistry (paraffin): 1:100-1:300ELISA: 1:5000Optimal dilutions to be determined by the researcher.
- Storage and Stability:May be stored at 4°C for short-term only.
- Aliquot to avoid repeated freezing and thawing.
- Store at -20°C.
- Aliquots are stable for 12 months after receipt.
- For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
仕様
- Size:100ul
- Host:rabbit
- Source Antibody:human
- Grade:Affinity Purified
- Purity:Purified by immunoaffinity chromatography.
- Form:Supplied as a liquid in PBS, 0.5% BSA, 0.02% sodium azide, 50% glycerol.
- Specificity:Recognizes endogenous levels of human Cot (phospho Ser400). Species Crossreactivity: mouse and rat
- Isotype:IgG
- Calc Applications Abbrev:E IHC
- Calc Crossreactivity:Hu Mo Rt
- Immunogen:Synthetic peptide corresponding to human Cot around the phosphorylation site of S400.
- Swiss Prot Number:P41279
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]